Skip to main content

Table 4 Baseline characteristics for patients aged 13 years and over (n = 64,929)

From: Assessing Asthma control in UK primary care: Use of routinely collected prospective observational consultation data to determine appropriateness of a variety of control assessment models

Issues assessed/discussed at consultation

Number

%

Age Mean (SD)

46.9 (SD 19.5)

 

Patient numbers by age band: 13-19 years

7,047

11

20-29 years

7,258

11

30-39 years

10,616

16

40-49 years

10,029

15

50-59 years

10,298

16

60-69 years

10,259

16

70+ years

9,422

15

Female

37,826

58

Body Mass Index (BMI) Mean (SD)

26.16 (SD 5.79)

 

Patient numbers by BMI band: ≤18

4,473

7

> 18-25

25,537

39

> 25-30

21,546

33

> 30

13,373

21

PEFR at consultation < 80% predicted

1,971

3

Days off in last 4 weeks due to asthma

8,382

13

Smoker

13,531

21

Symptoms in last 4 weeks

54,503

84

Inhaler Device(s) Technique observed as poor

6,789

10

Inhaler occasionally forgotten/not taken

18,869

29

Self management plan not in use prior to consultation

39,938

62

Temporary Increase in Inhaled Steroid since last review

3,157

5

Rescue Oral Steroid since last review

3,223

5

Emergency Nebulisation since last review

1,528

2

Over use of Inhaled Short Acting Bronchodilator*

30,360

47

Scheduled consult since last review

2,626

4

Unscheduled consult since last review

1,755

3

Telephone consult since last review

321

0.5

Home visit since last review

158

0.2

Outpatient visit since last review

95

0.1

A&E visit since last review

292

0.4

Admission to Hospital since last review

58

0.1

BTS Treatment Step prior to review: BTS Step 0

5,477

8

BTS Step 1

7,274

11

BTS Step 2

29,629

46

BTS Step 3

10,678

16

BTS Step 4

11,491

18

BTS Step 5

380

1

  1. *Overuse of Short Acting Bronchodilator = SAB inhaler required more than once every day in the four weeks prior to the consultation
  2. BTS = British Thoracic Society